{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:57:08Z","timestamp":1791233828055,"version":"4.1.0"},"reference-count":155,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordination for the improvement of Higher Education Personnel","doi-asserted-by":"publisher","award":["Finance Code 001"],"award-info":[{"award-number":["Finance Code 001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["407034\/2023-4"],"award-info":[{"award-number":["407034\/2023-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["405828\/2025-0"],"award-info":[{"award-number":["405828\/2025-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.cbi.2026.112309","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:52:21Z","timestamp":1788187941000},"page":"112309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Vanadium compounds in experimental diabetes: preclinical evidence on hyperglycemia, dyslipidemia, and mechanistic pathways from a scoping review"],"prefix":"10.1016","volume":"439","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-7641-3851","authenticated-orcid":false,"given":"Paula Rothbarth","family":"Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalia Mar\u00e7allo Peixoto","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane Mayrhofer Grocoske","family":"de Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateus Santana","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia Sthefani","family":"Calixto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9951-587X","authenticated-orcid":false,"given":"Luana Mota","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldo","family":"Picheth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiane Gomes","family":"de Moraes Rego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9913-9306","authenticated-orcid":false,"given":"Marcel Henrique Marcondes","family":"Sari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2026.112309_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/ndt\/gfaf177","article-title":"IDF diabetes Atlas 11th edition 2025: global prevalence and projections for 2050","volume":"41","author":"Duncan","year":"2025","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.cbi.2026.112309_bib2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.2337\/dc25-SINT","article-title":"Introduction and methodology: standards of care in diabetes\u20142025","volume":"48","author":"Balapattabi","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cbi.2026.112309_bib3","series-title":"Diretriz Da Sociedade Brasileira De Diabetes - Edi\u00e7\u00e3o 2025","article-title":"Diretriz da Sociedade Brasileira de Diabetes - Edi\u00e7\u00e3o 2025","author":"Bertoluci","year":"2025"},{"key":"10.1016\/j.cbi.2026.112309_bib4","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/qjmed\/hcn003","article-title":"A systematic review of vanadium oral supplements for glycaemic control in type 2 diabetes mellitus","volume":"101","author":"Smith","year":"2008","journal-title":"QJM: Int. J. Med."},{"key":"10.1016\/j.cbi.2026.112309_bib5","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ejmech.2018.04.061","article-title":"Current anti-diabetic agents and their molecular targets: a review","volume":"152","author":"Kerru","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2026.112309_bib6","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1089\/dia.2019.0157","article-title":"Sotagliflozin added to optimized insulin therapy leads to lower rates of clinically relevant hypoglycemic events at any HbA1c at 52 weeks in adults with type 1 diabetes","volume":"21","author":"Danne","year":"2019","journal-title":"Diabetes Technol. Therapeut."},{"key":"10.1016\/j.cbi.2026.112309_bib7","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s12011-018-1540-6","article-title":"Vanadium in biological action: Chemical, pharmacological aspects, and metabolic implications in diabetes mellitus","volume":"188","author":"Trevi\u00f1o","year":"2019","journal-title":"Biol. Trace Elem. Res."},{"issue":"3","key":"10.1016\/j.cbi.2026.112309_bib8","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s10534-025-00683-9","article-title":"Vanadium 8-hydroxyquinoline derivatives in medicine: current state and future outlook","volume":"38","author":"Kohanfekr","year":"2025","journal-title":"Biometals"},{"key":"10.1016\/j.cbi.2026.112309_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2019.04.073","article-title":"Synthesis and biological evaluation of vanadium complexes as novel anti-tumor agents","volume":"176","author":"Lu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2026.112309_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtemb.2022.126955","article-title":"Vanadium and diabetic dyslipidemia: a systematic review of animal studies","volume":"71","author":"Ghalichi","year":"2022","journal-title":"J. Trace Elem. Med. Biol."},{"key":"10.1016\/j.cbi.2026.112309_bib11","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.2147\/DMSO.S417700","article-title":"Exploring the biological effects of anti-diabetic vanadium compounds in the liver, heart and brain","volume":"17","author":"Dayanand","year":"2024","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"10.1016\/j.cbi.2026.112309_bib12","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1464-5491.2004.01381.x","article-title":"Insulino-mimetic and anti-diabetic effects of vanadium compounds","volume":"22","author":"Srivastava","year":"2005","journal-title":"Diabet. Med."},{"key":"10.1016\/j.cbi.2026.112309_bib13","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1172\/JCI117951","article-title":"Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent diabetes mellitus","volume":"95","author":"Cohen","year":"1995","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.cbi.2026.112309_bib14","first-page":"3311","article-title":"Metabolic effects of sodium metavanadate in humans with insulin-dependent and noninsulin-dependent diabetes mellitus in vivo and in vitro studies","volume":"80","author":"Goldfine","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cbi.2026.112309_bib15","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2337\/diab.45.5.659","article-title":"Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects","volume":"45","author":"Halberstam","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.cbi.2026.112309_bib16","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/S0026-0495(96)90013-X","article-title":"Effects of vanadyl sulfate on carbohydrate and lipid metabolism in patients with non-insulin-dependent diabetes mellitus","volume":"45","author":"Boden","year":"1996","journal-title":"Metabolism"},{"key":"10.1016\/j.cbi.2026.112309_bib17","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0026-0495(00)90418-9","article-title":"Metabolic effects of vanadyl sulfate in humans with non-insulin- dependent diabetes mellitus: in vivo and in vitro studies","volume":"49","author":"Goldfine","year":"2000","journal-title":"Metabolism"},{"key":"10.1016\/j.cbi.2026.112309_bib18","first-page":"1410","article-title":"Vanadyl sulfate improves hepatic and muscle insulin sensitivity in type 2 diabetes","volume":"86","author":"Cusi","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cbi.2026.112309_bib19","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1039\/c3mt00162h","article-title":"Coordination chemistry May explain pharmacokinetics and clinical response of Vanadyl sulfate in type 2 diabetic patients","volume":"5","author":"Willsky","year":"2013","journal-title":"Metallomics"},{"key":"10.1016\/j.cbi.2026.112309_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242115675","article-title":"Vanadium compounds with antidiabetic potential","volume":"24","author":"Amaral","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2026.112309_bib21","doi-asserted-by":"crossref","first-page":"11899","DOI":"10.1021\/acs.joc.5b02229","article-title":"Antidiabetic, chemical, and physical properties of organic vanadates as presumed transition-state inhibitors for phosphatases","volume":"80","author":"Crans","year":"2015","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.cbi.2026.112309_bib22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/XEB.0000000000000050","article-title":"Guidance for conducting systematic scoping reviews","volume":"13","author":"Peters","year":"2015","journal-title":"Int. J. Evid. Base. Healthc."},{"key":"10.1016\/j.cbi.2026.112309_bib23","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cbi.2026.112309_bib24","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2288-14-43","article-title":"SYRCLE's risk of bias tool for animal studies","volume":"14","author":"Hooijmans","year":"2014","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.cbi.2026.112309_bib25","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.2337\/diab.38.11.1390","article-title":"Long-term effects of vanadyl treatment on streptozocin-induced diabetes in rats","volume":"38","author":"Pederson","year":"1989","journal-title":"Diabetes"},{"key":"10.1016\/j.cbi.2026.112309_bib26","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/BF00285328","article-title":"Effect of vanadate administration on blood glucose and insulin levels as well as on the exocrine pancreatic function in streptozotocin-diabetic rats","volume":"32","author":"Bendayan","year":"1989","journal-title":"Diabetologia"},{"key":"10.1016\/j.cbi.2026.112309_bib27","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF00265092","article-title":"In vivo insulin resistance in streptozotocin-diabetic rats - evidence for reversal following oral vanadate treatment","volume":"32","author":"Blondel","year":"1989","journal-title":"Diabetologia"},{"key":"10.1016\/j.cbi.2026.112309_bib28","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.2337\/diab.39.11.1326","article-title":"Marked improvement of glucose homeostasis in diabetic ob\/ob mice given oral vanadate","volume":"39","author":"Brichard","year":"1990","journal-title":"Diabetes"},{"key":"10.1016\/j.cbi.2026.112309_bib29","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1139\/y90-069","article-title":"Enhanced in vivo sensitivity of vanadyl-treated diabetic rats to insulin","volume":"68","author":"Ramanadham","year":"1990","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.cbi.2026.112309_bib30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/1043-6618(90)90717-R","article-title":"Insulinic actions of vanadate in diabetic rats","volume":"22","author":"Sekar","year":"1990","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.cbi.2026.112309_bib31","article-title":"Impaired insulin action but normal insulin receptor activity in diabetic rat liver: effect of vanadate","volume":"258","author":"Blondel","year":"1990","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.cbi.2026.112309_bib32","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1600-0773.1991.tb01233.x","article-title":"Improvement of glucose homeostasis by oral vanadyl or vanadate treatment in diabetic rats is accompanied by negative side effects","volume":"68","author":"Domingo","year":"1991","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.cbi.2026.112309_bib33","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1172\/JCI115131","article-title":"Vanadate normalizes hyperglycemia in two mouse models of non-insulin-dependent diabetes mellitus","volume":"87","author":"Meyerovitch","year":"1991","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.cbi.2026.112309_bib34","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/00006676-199101000-00008","article-title":"Abnormal B-cell function in rats with non-insulin-dependent diabetes induced by neonatal streptozotocin: effect of in vivo insulin, phlorizin, or vanadate treatments","volume":"6","author":"Serradas","year":"1991","journal-title":"Pancreas"},{"key":"10.1016\/j.cbi.2026.112309_bib35","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0300-483X(91)90199-B","article-title":"Oral vanadium administration to streptozotocin-diabetic rats has marked negative side-effects which are independent of the form of vanadium used","volume":"66","author":"Domingo","year":"1991","journal-title":"Toxicology"},{"issue":"3","key":"10.1016\/j.cbi.2026.112309_bib36","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/BF00399953","article-title":"Long-term effectiveness of oral vanadyl sulphate in streptozotocin-diabetic rats","volume":"36","author":"Cam","year":"1993","journal-title":"Diabetologia"},{"key":"10.1016\/j.cbi.2026.112309_bib37","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1139\/y93-041","article-title":"Glucose-lowering effects of a new organic vanadium complex, bis(maltolato)oxovanadium(IV), can","volume":"71","author":"Yuen","year":"1993","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.cbi.2026.112309_bib38","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0303-7207(93)90259-M","article-title":"Vanadate treatment of diabetic rats reverses the impaired expression of genes involved in hepatic glucose metabolism: effects on glycolytic and gluconeogenic enzymes, and on glucose transporter GLUT2","volume":"91","author":"Brichard","year":"1993","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.cbi.2026.112309_bib39","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/BF00418369","article-title":"Tissue-specific correction of lipogenic enzyme gene expression in diabetic rats given vanadate","volume":"37","author":"Brichard","year":"1994","journal-title":"Diabetologia"},{"key":"10.1016\/j.cbi.2026.112309_bib40","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1600-0773.1994.tb01083.x","article-title":"One-year treatment of streptozotocin-induced diabetic rats with vanadyl sulphate","volume":"74","author":"Dai","year":"1994","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.cbi.2026.112309_bib41","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2337\/diab.43.1.9","article-title":"Effects of chronic vanadate administration in the STZ-induced diabetic rat. The antihyperglycemic action of vanadate is attributable entirely to its suppression of feeding","volume":"43","author":"Malabu","year":"1994","journal-title":"Diabetes"},{"key":"10.1016\/j.cbi.2026.112309_bib42","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF01075940","article-title":"Vanadate induces normolipidemia and a reduction in the levels of hepatic lipogenic enzymes in obese Zucker rat","volume":"153","author":"Pugazhenthi","year":"1995","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.cbi.2026.112309_bib43","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.2337\/diab.44.11.1274","article-title":"Hypoglycemic effects of peroxovanadium compounds in Sprague-Dawley and diabetic BB rats","volume":"44","author":"Yale","year":"1995","journal-title":"Diabetes"},{"key":"10.1016\/j.cbi.2026.112309_bib44","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0300-9084(95)80002-6","article-title":"Insulin-like effects of vanadate and selenate on the expression of glucose-6-phosphate dehydrogenase and fatty acid synthase in diabetic rats","volume":"77","author":"Berg","year":"1995","journal-title":"Biochimie"},{"key":"10.1016\/j.cbi.2026.112309_bib45","first-page":"55","volume":"73","author":"Yuen","year":"1995"},{"key":"10.1016\/j.cbi.2026.112309_bib46","first-page":"83","volume":"75","author":"Yao","year":"1997"},{"key":"10.1016\/j.cbi.2026.112309_bib47","volume":"272","author":"Yuen","year":"1997"},{"issue":"1","key":"10.1016\/j.cbi.2026.112309_bib48","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1023\/A:1007001818411","article-title":"Effects of bis (maltolato) oxovanadium (IV) on protein serine kinases in skeletal muscle of streptozotocin-diabetic rats","volume":"202","author":"Bhanot","year":"1999","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.cbi.2026.112309_bib49","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1600-0773.1999.tb00087.x","article-title":"Normalization of hyperglycaemia by oral vanadyl sulfate does not reverse diabetes-induced protection against cisplatin nephrotoxicity in streptozotocin-diabetic rats","volume":"85","author":"Sarangarajan","year":"1999","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.cbi.2026.112309_bib50","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0026-0495(99)90171-3","article-title":"Synergistic interaction of magnesium and vanadate on glucose metabolism in diabetic rats","volume":"48","author":"Matsuda","year":"1999","journal-title":"Metabolism"},{"key":"10.1016\/j.cbi.2026.112309_bib51","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/sj.bjp.0702311","article-title":"Effects of vanadium complexes with organic ligands on glucose metabolism: a comparison study in diabetic rats","volume":"126","author":"Reul","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cbi.2026.112309_bib52","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0168-8227(98)00120-X","article-title":"Acute and chronic oral administration of bis(maltolato)oxovanadium(IV) in Zucker diabetic fatty (ZDF) rats","volume":"43","author":"Yuen","year":"1999","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.cbi.2026.112309_bib53","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0026-0495(00)90132-X","article-title":"Gluconeogenesis in Non-obese diabetic (NOD) mice: in vivo effects of vanadate treatment on hepatic glucose-6-phosphatase and phosphoenolpyruvate carboxykinase","volume":"49","author":"Mosseri","year":"2000","journal-title":"Metabolism"},{"key":"10.1016\/j.cbi.2026.112309_bib54","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.2337\/diabetes.50.9.2061","article-title":"Combined treatment with benzylamine and low dosages of vanadate enhances glucose tolerance and reduces hyperglycemia in streptozotocin-induced diabetic rats","volume":"50","author":"Marti","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.cbi.2026.112309_bib55","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0162-0134(01)00192-1","article-title":"Amelioration of insulin resistance in diabetic ob\/ob mice by a new type of orally active insulin-mimetic vanadyl complex: Bis(1-oxy-2-pyridinethiolato)oxovanadium(IV) with VO(S2O2) coordination mode","volume":"85","author":"Takeshita","year":"2001","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.cbi.2026.112309_bib56","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1053\/meta.2001.23296","article-title":"Lack of in vivo effect of vanadium on GLUT4 translocation in white adipose tissue of streptozotocin-diabetic rats","volume":"50","author":"Cam","year":"2001","journal-title":"Metabolism"},{"key":"10.1016\/j.cbi.2026.112309_bib57","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1055\/s-2001-12404","article-title":"Decrease of hypothalamic neuropeptide Y gene expression by Vanadyl sulfate in Streptozotocin-induced diabetic rats","volume":"33","author":"Liu","year":"2001","journal-title":"Horm. Metab. Res."},{"issue":"2","key":"10.1016\/j.cbi.2026.112309_bib58","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1385\/BTER:80:2:159","article-title":"Effect of long-term treatment with vanadate in drinking water on KK mice with genetic non-insulin-dependent diabetes mellitus","volume":"80","author":"Ding","year":"2001","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.cbi.2026.112309_bib59","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1021\/ic000984t","article-title":"Insulin-enhancing vanadium(III) complexes","volume":"40","author":"Melchior","year":"2001","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.cbi.2026.112309_bib60","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1139\/y03-094","article-title":"Chronic glucose-lowering effects of rosiglitazone and bis(ethylmaltolato)oxovanadium(IV) in ZDF rats","volume":"81","author":"Yuen","year":"2003","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.cbi.2026.112309_bib61","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1046\/j.1463-1326.2003.00302.x","article-title":"Insulin mimetic effects of macrocyclic binuclear oxovanadium complexes on streptozotocin-induced experimental diabetes in rats","volume":"5","author":"Ramachandran","year":"2003","journal-title":"Diabetes Obes. Metabol."},{"key":"10.1016\/j.cbi.2026.112309_bib62","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1582-4934.2003.tb00247.x","article-title":"The influence of sodium metavanadate on the process of diabetogenesis in BB rats","volume":"7","author":"Cheta","year":"2003","journal-title":"J. Cell Mol. Med."},{"issue":"1","key":"10.1016\/j.cbi.2026.112309_bib63","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1385\/BTER:95:1:73","article-title":"Effects of vanadyl sulfate on kidney in experimental diabetes","volume":"95","author":"Yanardag","year":"2003","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.cbi.2026.112309_bib64","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1631\/jzus.2004.1245","article-title":"Effects of vanadate on the activities of mice glucokinase and hexokinase","volume":"5","author":"zhi Xu","year":"2004","journal-title":"J. Zhejiang Univ. - Sci."},{"key":"10.1016\/j.cbi.2026.112309_bib65","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.diabres.2005.02.003","article-title":"Protective effect of vanadyl sulfate on the pancreas of streptozotocin-induced diabetic rats","volume":"70","author":"Bolkent","year":"2005","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"4","key":"10.1016\/j.cbi.2026.112309_bib66","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/BF02703722","article-title":"Amelioration of altered antioxidant status and membrane linked functions by vanadium andTrigonella in alloxan diabetic rat brains","volume":"30","author":"Siddiqui","year":"2005","journal-title":"J. Biosci."},{"key":"10.1016\/j.cbi.2026.112309_bib67","doi-asserted-by":"crossref","first-page":"5416","DOI":"10.1021\/ic048331q","article-title":"Aqueous chemistry of the VanadiumIII (VIII) and the VIII\u2212Dipicolinate systems and a comparison of the effect of three oxidation states of vanadium compounds on diabetic hyperglycemia in rats","volume":"44","author":"Bugly\u00f3","year":"2005","journal-title":"Inorg. Chem."},{"issue":"3","key":"10.1016\/j.cbi.2026.112309_bib68","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1385\/BTER:104:3:233","article-title":"Effects of vanadyl sulfate on liver of streptozotocin-induced diabetic rats","volume":"104","author":"Koyuturk","year":"2005","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.cbi.2026.112309_bib69","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.jinorgbio.2005.01.018","article-title":"Sodium orthovanadate exerts influence on liver Golgi complexes from control and streptozotocin-diabetic rats","volume":"99","author":"Kordowiak","year":"2005","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.cbi.2026.112309_bib70","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s11010-005-6988-y","article-title":"Amelioration of diabetic dyslipidemia by macrocyclic binuclear oxovanadium complex on streptozotocin induced diabetic rats","volume":"272","author":"Ramachandran","year":"2005","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.cbi.2026.112309_bib71","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jinorgbio.2004.10.033","article-title":"A new orally active antidiabetic vanadyl complex - Bis(\u03b1- furancarboxylato)oxovanadium(IV)","volume":"99","author":"Xie","year":"2005","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.cbi.2026.112309_bib72","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jtemb.2004.12.001","article-title":"Effect of bis[curcumino]oxovanadium complex on non-diabetic and streptozotocin-induced diabetic rats","volume":"18","author":"Majithiya","year":"2005","journal-title":"J. Trace Elem. Med. Biol."},{"key":"10.1016\/j.cbi.2026.112309_bib73","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00383-006-1704-x","article-title":"The role of hyperglycemia in FAT\/CD36 expression and function","volume":"22","author":"Chen","year":"2006","journal-title":"Pediatr. Surg. Int."},{"key":"10.1016\/j.cbi.2026.112309_bib74","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbrc.2006.05.003","article-title":"Improvement of diabetes, obesity and hypertension in type 2 diabetic KKAy mice by bis(allixinato)oxovanadium(IV) complex","volume":"345","author":"Adachi","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.cbi.2026.112309_bib75","first-page":"17","article-title":"Low doses of vanadate and Trigonella synergistically regulate Na+\/K+-ATPase activity and GLUT4 translocation in alloxan-diabetic rats","volume":"285","author":"Siddiqui","year":"2005","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.cbi.2026.112309_bib76","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cca.2005.12.028","article-title":"Effects of bis(\u03b1-furancarboxylato)oxovanadium(IV) on non-diabetic and streptozotocin-diabetic rats","volume":"368","author":"Gao","year":"2006","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cbi.2026.112309_bib77","author":"Dabro\u015b"},{"key":"10.1016\/j.cbi.2026.112309_bib78","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1002\/cmdc.200700132","article-title":"Amelioration of hyperglycemia and metabolic syndromes in type 2 diabetic KKA(y) mice by poly(gamma-glutamic acid)oxovanadium(IV) complex","volume":"2","author":"Karmaker","year":"2007","journal-title":"ChemMedChem"},{"key":"10.1016\/j.cbi.2026.112309_bib79","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.arcmed.2006.09.018","article-title":"Vanadyl sulfate, taurine, and combined Vanadyl sulfate and taurine treatments in diabetic rats: effects on the oxidative and antioxidative systems","volume":"38","author":"Tas","year":"2007","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.cbi.2026.112309_bib80","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1211\/jpp.59.3.0014","article-title":"Improvement of hyperglycaemia and metabolic syndromes in type 2 diabetic KKAy mice by oral treatment with [meso-tetrakis(4-sulfonatophenyl) porphyrinato]oxovanadium(IV)(4-) complex","volume":"59","author":"Saha","year":"2007","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.cbi.2026.112309_bib81","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s10534-008-9142-y","article-title":"Vanadium-enriched chickpea sprout ameliorated hyperglycemia and impaired memory in streptozotocin-induced diabetes rats","volume":"21","author":"Mao","year":"2008","journal-title":"Biometals"},{"key":"10.1016\/j.cbi.2026.112309_bib82","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s12011-007-8049-8","article-title":"Anti-diabetic effects of cesium aqua (N,N\u2019-ethylene(salicylideneiminato)-5-sulfonato) oxovanadium (IV) dihydrate in streptozotocin-induced diabetic rats","volume":"121","author":"Li","year":"2008","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.cbi.2026.112309_bib83","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1177\/0885328207078067","article-title":"Antidiabetic activity of the orally effective vanadyl-poly (gamma-glutamic acid) complex in streptozotocin(STZ)-induced type 1 diabetic mice","volume":"22","author":"Karmaker","year":"2008","journal-title":"J. Biomater. Appl."},{"key":"10.1016\/j.cbi.2026.112309_bib84","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cca.2007.10.014","article-title":"The antilipolytic action of bis(\u03b1-furancarboxylato)oxovanadium(IV) in adipocytes","volume":"388","author":"Gao","year":"2008","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cbi.2026.112309_bib85","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s12011-009-8355-4","article-title":"Hypoglycemic activity of Grifola frondosa rich in vanadium","volume":"131","author":"Cui","year":"2009","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.cbi.2026.112309_bib86","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jinorgbio.2008.11.011","article-title":"Anti-diabetic effects of sodium 4-amino-2,6-dipicolinatodioxovanadium(V) dihydrate in streptozotocin-induced diabetic rats","volume":"103","author":"Li","year":"2009","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.cbi.2026.112309_bib87","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.ejmech.2008.04.023","article-title":"Synthesis, characterization and antidiabetic properties of N1-2,4-dihydroxybenzylidene-N4-2-hydroxybenzylidene-S-methyl-thiosemicarbazidato-oxovanadium(IV)","volume":"44","author":"Yanardag","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2026.112309_bib88","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1016\/j.ejmech.2010.02.010","article-title":"A new insulin-enhancing agent: [N,N\u2032-bis(4-hydroxysalicylidene)-o-phenylene-diamine]oxovanadium(IV) and its permeability and cytotoxicity","volume":"45","author":"jin Xie","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2026.112309_bib89","author":"Karmaker"},{"key":"10.1016\/j.cbi.2026.112309_bib90","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s10534-011-9452-3","article-title":"Influence of vanadium supplementation on oxidative stress factors in the muscle of STZ-diabetic rats","volume":"24","author":"Kurt","year":"2011","journal-title":"Biometals"},{"key":"10.1016\/j.cbi.2026.112309_bib91","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s12011-011-9139-1","article-title":"Methoxy VO-salen stimulates pancreatic \u03b2 cell survival by upregulation of eNOS and downregulation of apoptosis in STZ-induced diabetic rats","volume":"144","author":"Roy","year":"2011","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.cbi.2026.112309_bib92","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s12011-012-9437-2","article-title":"Comparison of effects of vanadium absorbed by Coprinus comatus with those of inorganic vanadium on bone in streptozotocin-diabetic rats","volume":"149","author":"Wang","year":"2012","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.cbi.2026.112309_bib93","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1017\/S0007114511006131","article-title":"Effect of bis(maltolato)oxovanadium (IV) (BMOV) on selenium nutritional status in diabetic streptozotocin rats","volume":"108","author":"Sanchez-Gonzalez","year":"2012","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.cbi.2026.112309_bib94","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/cbf.2819","article-title":"Beneficial effects of Trigonella foenum graecum and sodium orthovanadate on metabolic parameters in experimental diabetes","volume":"30","author":"Kumar","year":"2012","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.cbi.2026.112309_bib95","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00216-011-5286-7","article-title":"Absorption, transport and insulin-mimetic properties of bis(maltolato)oxovanadium (IV) in streptozotocin-induced hyperglycemic rats by integrated mass spectrometric techniques","volume":"402","author":"Iglesias-Gonz\u00e1lez","year":"2012","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.cbi.2026.112309_bib96","author":"Velescu"},{"key":"10.1016\/j.cbi.2026.112309_bib97","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s12011-013-9827-0","article-title":"Effect of lower doses of vanadate in combination with Azadirachta indica leaf extract on hepatic and renal antioxidant enzymes in streptozotocin-induced diabetic rats","volume":"156","author":"Upreti","year":"2013","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.cbi.2026.112309_bib98","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1177\/0960327113478445","article-title":"Protective effect of vanadyl sulfate on skin injury in streptozotocin-induced diabetic rats","volume":"32","author":"Tunali","year":"2013","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.cbi.2026.112309_bib99","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s12011-013-9689-5","article-title":"Bis(\u03b1-furancarboxylato)oxovanadium(IV) exerts durable antidiabetic effects and suppresses matrix metalloproteinase-2 activity in spontaneous type 2 diabetic KKAy mice","volume":"153","author":"Li","year":"2013","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.cbi.2026.112309_bib100","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1684\/mrh.2013.0342","article-title":"Aggravation by vanadium of magnesium deficiency in STZ-induced diabetic rats","volume":"26","author":"Berm\u00fadez-Pe\u00f1a","year":"2013","journal-title":"Magnes. Res."},{"key":"10.1016\/j.cbi.2026.112309_bib101","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s10856-013-4852-2","article-title":"Decreasing the diabetic complication by vanadyl(VO)2+\/vitamin B 6 complex in alloxan-induced diabetic mice","volume":"24","author":"El-Shenawy","year":"2013","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"10.1016\/j.cbi.2026.112309_bib102","first-page":"173","article-title":"Does the Relief of glucose toxicity act as a mediator in proliferative actions of vanadium on pancreatic islet beta cells in Streptozocin diabetic rats?","volume":"18","author":"Pirmoradi","year":"2014","journal-title":"Iran. Biomed. J."},{"key":"10.1016\/j.cbi.2026.112309_bib103","doi-asserted-by":"crossref","first-page":"105","DOI":"10.17305\/bjbms.2014.2273","article-title":"Ameliorative effect of vanadium on oxidative stress in stomach tissue of diabetic rats","volume":"14","author":"Yilmaz-Ozden","year":"2014","journal-title":"Biomol. Biomed."},{"key":"10.1016\/j.cbi.2026.112309_bib104","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jdiacomp.2014.02.001","article-title":"A new oxovanadium complex enhances renal function by improving insulin signaling pathway in diabetic mice","volume":"28","author":"Liu","year":"2014","journal-title":"J. Diabet. Complicat."},{"key":"10.1016\/j.cbi.2026.112309_bib105","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/540242","article-title":"Vanadyl sulfate treatment stimulates proliferation and regeneration of beta cells in pancreatic islets","volume":"2014","author":"Missaoui","year":"2014","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.cbi.2026.112309_bib106","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.saa.2014.07.074","article-title":"Synthesis, spectroscopic, structural and thermal characterizations of vanadyl(IV) adenine complex prospective as antidiabetic drug agent N N NH 2 HN N N N H 2 N NH N .SO 4","volume":"135","author":"El-Megharbel","year":"2015","journal-title":"Spectrochim. Acta Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.cbi.2026.112309_bib107","doi-asserted-by":"crossref","first-page":"122","DOI":"10.14712\/23362936.2015.51","article-title":"Sodium orthovanadate and trigonella foenum graecum prevents neuronal parameters decline and impaired glucose homeostasis in alloxan diabetic rats","volume":"116","author":"Kumar","year":"2015","journal-title":"Prague Med. Rep."},{"key":"10.1016\/j.cbi.2026.112309_bib108","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/0394632015576036","article-title":"Synthesis, characterization, and efficacy evaluation of a new anti-diabetic vanadyl(II) thiamine hydrochloride complex in streptozotocin-induced diabetic rats","volume":"28","author":"El-Shazly","year":"2015","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.cbi.2026.112309_bib109","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jtemb.2015.07.007","article-title":"Ameliorative effect of vanadyl(IV)\u2013ascorbate complex on high-fat high-sucrose diet-induced hyperglycemia, insulin resistance, and oxidative stress in mice","volume":"32","author":"Liu","year":"2015","journal-title":"J. Trace Elem. Med. Biol."},{"key":"10.1016\/j.cbi.2026.112309_bib110","first-page":"18","article-title":"Quantitative assessment of proliferative effects of oral vanadium on pancreatic islet volumes and beta cell numbers of diabetic rats, Iran","volume":"20","author":"Pirmoradi","year":"2016","journal-title":"Biomed. J."},{"key":"10.1016\/j.cbi.2026.112309_bib111","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1177\/0394632017719601","article-title":"Synthesis of a new insulin-mimetic anti-diabetic drug containing vitamin A and vanadium(IV) salt: Chemico-biological characterizations","volume":"30","author":"Adam","year":"2017","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.cbi.2026.112309_bib112","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1007\/s00044-017-1895-9","article-title":"A novel PTP1b inhibitor vanadium-flavone complex: synthesis and pharmacodynamic evaluation in streptozotocin-induced diabetic mice","volume":"26","author":"Duan","year":"2017","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.cbi.2026.112309_bib113","article-title":"Evaluation of PROTECTIVE effects of quercetin and vanadyl sulphate in alloxan induced diabetes model","volume":"65","author":"Velescu","year":"2017","journal-title":"FARMACIA"},{"key":"10.1016\/j.cbi.2026.112309_bib114","first-page":"249","article-title":"Effects of sodium tungstate and vanadyl sulphate on the liberation of prostanoids of the mesenteric vascular bed in diabetic rats","volume":"30","author":"Lee","year":"2018","journal-title":"Cl\u00edn. Invest. Arterioscler."},{"key":"10.1016\/j.cbi.2026.112309_bib115","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4077\/CJP.2018.BAG523","article-title":"Modulatory effect of concomitant administration of insulin and vanadium on inflammatory biomarkers in type 2 diabetic rats: role of adiponectin","volume":"61","author":"Bin-Jaliah","year":"2018","journal-title":"Chin. J. Physiol."},{"key":"10.1016\/j.cbi.2026.112309_bib116","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s11011-017-0153-7","article-title":"Long-term treatment of diabetic rats with vanadyl sulfate or insulin attenuate acute focal cerebral ischemia\/reperfusion injury via their antiglycemic effect","volume":"33","author":"Ahmadi-Eslamloo","year":"2018","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.cbi.2026.112309_bib117","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/13813455.2019.1573840","article-title":"The impact of concomitant administration of vanadium and insulin on endothelial dysfunction markers (PAI-1 and ET-1) in type 1 diabetic rats","volume":"127","author":"Morsy","year":"2021","journal-title":"Arch. Physiol. Biochem."},{"key":"10.1016\/j.cbi.2026.112309_bib118","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1139\/cjpp-2019-0369","article-title":"The effect of dioxidovanadium complex (V) on hepatic function in streptozotocin-induced diabetic rats","volume":"97","author":"Sibiya","year":"2019","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.cbi.2026.112309_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2019.03.020","article-title":"Synthesis, crystal structures and insulin-like activity of three new oxidovanadium(V) complexes with aroylhydrazone ligand","volume":"196","author":"Zhou","year":"2019","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.cbi.2026.112309_bib120","first-page":"1594","article-title":"Antioxidant status in STZ-induced diabetic rats treated with Vanadium pentoxide nanoparticles","volume":"53","author":"Vijay","year":"2019","journal-title":"Indian J. Anim. Res."},{"key":"10.1016\/j.cbi.2026.112309_bib121","doi-asserted-by":"crossref","first-page":"9219","DOI":"10.1039\/D0NR00810A","article-title":"Vanadium coordination compounds loaded on graphene quantum dots (GQDs) exhibit improved pharmaceutical properties and enhanced anti-diabetic effects","volume":"12","author":"Du","year":"2020","journal-title":"Nanoscale"},{"key":"10.1016\/j.cbi.2026.112309_bib122","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10534-020-00270-0","article-title":"Cardio-protective effects of a dioxidovanadium(V) complex in male sprague-dawley rats with streptozotocin-induced diabetes","volume":"34","author":"Mbatha","year":"2021","journal-title":"Biometals"},{"key":"10.1016\/j.cbi.2026.112309_bib123","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.2147\/DMSO.S214726","article-title":"Heamanetic effects of a Dioxidovanadium(V) complex in STZ-Induced diabetic Male sprague dawley rats","volume":"14","author":"Xulu","year":"2021","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"10.1016\/j.cbi.2026.112309_bib124","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1139\/cjpp-2020-0278","article-title":"Anti-hyperglycaemic effects of dioxidovanadium complex cis-[VO2(obz)py] avert kidney dysfunction in streptozotocin-induced diabetic male Sprague-Dawley rats","volume":"99","author":"Mbatha","year":"2021","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.cbi.2026.112309_bib125","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5372103","article-title":"A dioxidovanadium complex cis-[VO2 (obz) py] attenuates Hyperglycemia in Streptozotocin (STZ)-induced diabetic Male sprague-dawley rats via increased GLUT4 and glycogen synthase expression in the skeletal muscle","volume":"2022","author":"Mbatha","year":"2022","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.cbi.2026.112309_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2023.112127","article-title":"The antihyperglycemic and hypolipidemic activities of a sulfur-oxidovanadium(IV) complex","volume":"241","author":"Lima","year":"2023","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.cbi.2026.112309_bib127","doi-asserted-by":"crossref","DOI":"10.3390\/ph17040486","article-title":"A non-toxic binuclear Vanadium(IV) complex as insulin Adjuvant improves the glycemic control in Streptozotocin-induced diabetic rats","volume":"17","author":"Lopes","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.cbi.2026.112309_bib128","doi-asserted-by":"crossref","DOI":"10.3390\/ph17060760","article-title":"Dexamethasone-induced insulin resistance attenuation by oral Sulfur\u2013Oxidovanadium(IV) complex treatment in mice","volume":"17","author":"Batista","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.cbi.2026.112309_bib129","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1152\/jappl.1998.84.2.569","article-title":"Kinetic analysis and comparison of uptake, distribution, and excretion of 48V-labeled compounds in rats","volume":"84","author":"Setyawati","year":"1998","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.cbi.2026.112309_bib130","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.jinorgbio.2006.08.016","article-title":"Vanadium in diabetes: 100 years from phase 0 to phase I","volume":"100","author":"Thompson","year":"2006","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.cbi.2026.112309_bib131","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0010-8545(01)00447-7","article-title":"Antidiabetic vanadium(IV) and zinc(II) complexes","volume":"226","author":"Sakurai","year":"2002","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.cbi.2026.112309_bib132","series-title":"Bioinorganic Vanadium Chemistry","author":"Rehder","year":"2008"},{"key":"10.1016\/j.cbi.2026.112309_bib133","first-page":"12759","article-title":"Reaction chemistry of BMOV, bis(maltolato)oxovanadium(IV), a potent insulin mimetic agent","volume":"117","author":"Caravan","year":"2002","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.cbi.2026.112309_bib134","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1365-2125.2003.01711.x","article-title":"Pharmacokinetics of vanadium in humans after intravenous administration of a vanadium containing albumin solution","volume":"55","author":"Heinemann","year":"2003","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.cbi.2026.112309_bib135","article-title":"Prevalence of dyslipidemia in patients with type 2 diabetes mellitus: a cross-sectional study","volume":"13","author":"Al Ghadeer","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.cbi.2026.112309_bib136","doi-asserted-by":"crossref","DOI":"10.3390\/ph18091276","article-title":"Acetyl-CoA carboxylase inhibitors for nonalcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials","volume":"18","author":"Hasanatuludhhiyah","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.cbi.2026.112309_bib137","doi-asserted-by":"crossref","DOI":"10.1194\/jlr.R800079-JLR200","article-title":"Fatty acid metabolism: target for metabolic syndrome","volume":"50","author":"Wakil","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cbi.2026.112309_bib138","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1023\/A:1007075204494","article-title":"Anti-diabetic and toxic effects of vanadium compounds","volume":"206","author":"Srivastava","year":"2000","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.cbi.2026.112309_bib139","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1021\/cr020607t","article-title":"The chemistry and biochemistry of vanadium and the biological activities exerted by vanadium compounds","volume":"104","author":"Crans","year":"2004","journal-title":"Chem. Rev."},{"key":"10.1016\/j.cbi.2026.112309_bib140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/diacare.39.1.1","article-title":"Insulin-mimetic effects of vanadate. Possible implications for future treatment of diabetes","volume":"39","author":"Shechter","year":"1990","journal-title":"Diabetes"},{"key":"10.1016\/j.cbi.2026.112309_bib141","series-title":"Provisional Peer-Reviewed Toxicity Values (PPRTV): Vanadium and Compounds (Except Vanadium Pentoxide)","year":"2009"},{"key":"10.1016\/j.cbi.2026.112309_bib142","series-title":"Toxicological Profile for Vanadium","year":"2012"},{"issue":"6","key":"10.1016\/j.cbi.2026.112309_bib143","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1172\/JCI117951","article-title":"Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent diabetes mellitus","volume":"95","author":"Cohen","year":"1995","journal-title":"J. Clin. Investig."},{"issue":"5","key":"10.1016\/j.cbi.2026.112309_bib144","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2337\/diab.45.5.659","article-title":"Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects","volume":"45","author":"Halberstam","year":"1996","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.cbi.2026.112309_bib145","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/S0026-0495(96)90013-X","article-title":"Effects of vanadyl sulfate on carbohydrate and lipid metabolism in patients with non-insulin-dependent diabetes mellitus","volume":"45","author":"Boden","year":"1996","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.cbi.2026.112309_bib146","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0026-0495(00)90418-9","article-title":"Metabolic effects of vanadyl sulfate in humans with non-insulin-dependent diabetes mellitus: in vivo and in vitro studies","volume":"49","author":"Goldfine","year":"2000","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.cbi.2026.112309_bib147","first-page":"1410","article-title":"Vanadyl sulfate improves hepatic and muscle insulin sensitivity in type 2 diabetes","volume":"86","author":"Cusi","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.cbi.2026.112309_bib148","article-title":"The ARRIVE guidelines 2.0: updated guidelines for reporting animal research","volume":"18","author":"Percie du Sert","year":"2020","journal-title":"PLoS Biol."},{"key":"10.1016\/j.cbi.2026.112309_bib149","article-title":"A comprehensive review of anti-diabetic activity of vanadium-based complexes via PTP1B inhibition mechanism","volume":"5","author":"Shaik","year":"2023","journal-title":"Results Chem."},{"issue":"21","key":"10.1016\/j.cbi.2026.112309_bib150","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242115675","article-title":"Vanadium compounds with antidiabetic potential: advances in coordination chemistry, biological activity, and mechanisms of action","volume":"24","author":"Amaral","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2026.112309_bib151","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/cbdd.14275","article-title":"A comprehensive review on the research progress of protein tyrosine phosphatase 1B (PTP1B) inhibitors as antidiabetic agents","volume":"102","author":"Agrawal","year":"2023","journal-title":"Chem. Biol. Drug Des."},{"issue":"6","key":"10.1016\/j.cbi.2026.112309_bib152","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/s41574-023-00818-3","article-title":"Mammalian models of diabetes mellitus, with a focus on type 2 diabetes mellitus","volume":"19","author":"Lutz","year":"2023","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.cbi.2026.112309_bib153","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1359685","article-title":"Animal models for type 1 and type 2 diabetes: advantages and limitations","volume":"15","author":"Singh","year":"2024","journal-title":"Front. Endocrinol."},{"issue":"9","key":"10.1016\/j.cbi.2026.112309_bib154","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/jdi.14034","article-title":"Contribution of animal models to diabetes research: its history, significance, and translation to humans","volume":"14","author":"Yagihashi","year":"2023","journal-title":"J. Diabetes Investig."},{"issue":"5","key":"10.1016\/j.cbi.2026.112309_bib155","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/ATVBAHA.111.237693","article-title":"Animal models of atherosclerosis","volume":"32","author":"Getz","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279726004175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279726004175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:24:06Z","timestamp":1791231846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279726004175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":155,"alternative-id":["S0009279726004175"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2026.112309","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vanadium compounds in experimental diabetes: preclinical evidence on hyperglycemia, dyslipidemia, and mechanistic pathways from a scoping review","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2026.112309","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"112309"}}